TJN-598

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTJN-598
Drug Alias NameTJN-598
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsTumor necrosis factor inhibitors
TargetsTransforming growth factor beta 1Tumor necrosis factor
Therapy Area/IndicationsGlomerulonephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTSUMURA & CO
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTSUMURA & CO
Active IndicationsN/A
Inactive IndicationsGlomerulonephritis

Other Information

ATC CodeN/A
Related LinksN/A